USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 169 filers reported holding USANA HEALTH SCIENCES INC in Q3 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $840,000 | +4.9% | 8,200 | 0.0% | 0.01% | +11.1% |
Q1 2021 | $801,000 | +71.2% | 8,200 | +35.1% | 0.01% | +50.0% |
Q4 2020 | $468,000 | +4.5% | 6,070 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $448,000 | -76.8% | 6,070 | -77.0% | 0.01% | -77.8% |
Q2 2020 | $1,935,000 | +27.0% | 26,350 | -0.1% | 0.03% | +12.5% |
Q1 2020 | $1,524,000 | -25.8% | 26,375 | 0.0% | 0.02% | +14.3% |
Q4 2019 | $2,055,000 | +12.3% | 26,375 | -1.4% | 0.02% | +5.0% |
Q3 2019 | $1,830,000 | -18.2% | 26,750 | -5.0% | 0.02% | -16.7% |
Q2 2019 | $2,236,000 | -6.8% | 28,150 | -1.6% | 0.02% | -7.7% |
Q1 2019 | $2,400,000 | +1916.8% | 28,610 | +2746.8% | 0.03% | +1200.0% |
Q4 2018 | $119,000 | -1.7% | 1,005 | 0.0% | 0.00% | +100.0% |
Q3 2018 | $121,000 | -41.8% | 1,005 | -44.3% | 0.00% | -50.0% |
Q2 2018 | $208,000 | +20700.0% | 1,805 | +12792.9% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | -94.1% | 14 | -88.4% | 0.00% | – |
Q3 2016 | $17,000 | +30.8% | 121 | 0.0% | 0.00% | – |
Q2 2016 | $13,000 | -7.1% | 121 | +6.1% | 0.00% | – |
Q1 2016 | $14,000 | -95.5% | 114 | -95.3% | 0.00% | -100.0% |
Q4 2015 | $308,000 | -95.9% | 2,414 | -95.7% | 0.00% | -96.2% |
Q3 2015 | $7,601,000 | +1048.2% | 56,714 | +1070.3% | 0.08% | +900.0% |
Q2 2015 | $662,000 | -84.8% | 4,846 | -87.6% | 0.01% | -83.7% |
Q1 2015 | $4,358,000 | +8.3% | 39,220 | 0.0% | 0.05% | +6.5% |
Q4 2014 | $4,024,000 | +320.5% | 39,220 | +208.8% | 0.05% | +58.6% |
Q1 2014 | $957,000 | -57.3% | 12,700 | -50.8% | 0.03% | -70.1% |
Q3 2013 | $2,239,000 | -23.6% | 25,800 | -36.3% | 0.10% | -5.8% |
Q2 2013 | $2,931,000 | – | 40,500 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |